As promised, the Food and Drug Administration (FDA) will finally allow the Plan B One-Step morning after pill to be sold to women of all ages, and will protect it from generic competition for the next three years.
According to Wednesday's decision, generic drug makers can apply to the FDA to sell generic versions of the emergency contraceptive starting in 2016. It's a bit complicated though—the FDA has removed all age restrictions from the sale of Plan B, but any generic versions will only be available to those 17 and older. That means, though both versions will be sold over the counter, anyone younger than 17 will still have to pay the $50 to get brand-name Plan B, while those older can pay about $40 for the generic version. But not until 2016, of course.